{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:27:44Z","timestamp":1762475264857,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T00:00:00Z","timestamp":1630713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007458","name":"Qatar Foundation","doi-asserted-by":"publisher","award":["NPRP11S-0117-180326"],"award-info":[{"award-number":["NPRP11S-0117-180326"]}],"id":[{"id":"10.13039\/100007458","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007833","name":"Hamad Medical Corporation","doi-asserted-by":"publisher","award":["IRGC-04-SI-17-151"],"award-info":[{"award-number":["IRGC-04-SI-17-151"]}],"id":[{"id":"10.13039\/100007833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jdcr.2021.09.002","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T18:41:36Z","timestamp":1631126496000},"page":"164-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Treatment and molecular profiling of acrodermatitis continua of Hallopeau during pregnancy using targeted therapy"],"prefix":"10.1016","volume":"16","author":[{"given":"Sara","family":"Al-Khawaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roopesh","family":"Krishnankutty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulab","family":"Sher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khairunnisa","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg","family":"Buddenkotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Steinhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jdcr.2021.09.002_bib1","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/jdv.14386","article-title":"European consensus statement on phenotypes of pustular psoriasis","volume":"31","author":"Navarini","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jdcr.2021.09.002_bib2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bjd.16232","article-title":"Pustular psoriasis and related pustular skin diseases","volume":"178","author":"Bachelez","year":"2018","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2021.09.002_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaci.2018.06.038","article-title":"Clinical and genetic differences between pustular psoriasis subtypes","volume":"143","author":"Twelves","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.jdcr.2021.09.002_bib4","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jid.2016.04.038","article-title":"IL36RN mutations affect protein expression and function: a basis for genotype-phenotype correlation in pustular diseases","volume":"136","author":"Tauber","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jdcr.2021.09.002_bib5","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ajhg.2014.04.005","article-title":"AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking","volume":"94","author":"Setta-Kaffetzi","year":"2014","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.jdcr.2021.09.002_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09546634.2019.1628170","article-title":"Treatment of acrodermatitis continua of Hallopeau with ixekizumab","volume":"32","author":"Miller","year":"2021","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.jdcr.2021.09.002_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5152\/eurjrheum.2015.0072","article-title":"Successful treatment of acrodermatitis continua of Hallopeau associated with psoriatic arthritis with adalimumab","volume":"2","author":"Lefkir","year":"2015","journal-title":"Eur J Rheumatol"},{"issue":"2","key":"10.1016\/j.jdcr.2021.09.002_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000367690","article-title":"Acrodermatitis continua of Hallopeau treated successfully with ustekinumab and acitretin after failure of tumour necrosis factor blockade and anakinra","volume":"230","author":"Saunier","year":"2015","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.jdcr.2021.09.002_bib9","doi-asserted-by":"crossref","first-page":"e12460","DOI":"10.1111\/dth.12460","article-title":"Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents","volume":"30","author":"Ad\u0131\u015fen","year":"2017","journal-title":"Dermatol Ther"},{"issue":"10","key":"10.1016\/j.jdcr.2021.09.002_bib10","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/jdv.16265","article-title":"Efficacy and safety of TNF blockers and of ustekinumab in palmoplantar pustulosis and in acrodermatitis continua of Hallopeau","volume":"34","author":"Husson","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512621006287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512621006287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:23:00Z","timestamp":1762474980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512621006287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":10,"alternative-id":["S2352512621006287"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.09.002","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment and molecular profiling of acrodermatitis continua of Hallopeau during pregnancy using targeted therapy","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2021.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}